Amneal Pharmaceuticals Inc (NYSE:AMRX)

4.93
Delayed Data
As of Jul 30
 0.00 / 0.00%
Today’s Change
3.45
Today|||52-Week Range
7.45
+7.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line17.5M-20.3M-124.8M-50.5M
 
 
 
 
 
Depreciation43.0M47.5M48.9M50.7M
 
 
 
 
 
Total Other Cash Flow-29.9M77.0M132.9M40.7M
 
 
 
 
 
Funds From Operations36.4M103.9M47.1M32.5M
 
 
 
 
 
Funds From/For Other Operating Expenses29.2M-155.8M155.5M11.4M
 
 
 
 
 
Net Cash Flow - Operating Activities7.2M259.7M-108.4M21.1M
 
 
 
 
 
 
InvestingCapital Expenditures-26.5M-20.0M-18.0M-11.6M
 
 
 
 
 
Fixed Asset Disposal0.0025.3M0.0034.8M
 
 
 
Net Assets From Acquisitions -3.3M-11.8M-5.5M1.9M
 
 
 
 
 
Net Cash Flow Investing-40.8M-6.5M-23.5M-24.9M
 
 
 
 
 
 
FinancingShort Term Borrowings-14.8M-60.2M0.000.00
 
 
 
Long Term Borrowings80.0M-25.0M0.000.00
 
 
 
Long Term Debt Reduction83.0M-98.9M-7.4M-7.0M
 
 
 
 
 
Net Proceeds Stock Sale1.2M635.0K1.0M375.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.000.000.00--
Other Uses - Financing11.8M23.8M13.5M921.0K
 
 
 
 
 
Net Cash Flow - Financing137.6M-207.1M-19.9M-7.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-351.0K534.0K-296.0K1.6M
 
 
 
 
 
 
Net Change In Cash104.0M46.1M-151.7M-11.3M